Although we have fully demonstrated that HCG18 was potential marker for cholangiocarcinoma and contributed to tumor growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway. Here, HCG18 is linked to cholangiocarcinoma.